US › Healthcare

INVO Fertility, Inc. (IVF)

US · Healthcare · Medical Devices

$0.93-0.49%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$2.2M

Revenue YoY

+16.7%

Net profit

$888,740

EPS

$0.35

EPS estimate

$-5.60

Net margin

40.9%

EPS came in at 0.35 against a street estimate of -5.60 — a beat of 106.2%.

Key statistics

Market cap

$2.4M

P/E

0.0

Forward P/E

0.0

P/B

0.15

Book value

$7.01

EPS (TTM)

$363.47

52-week high

$56.00

52-week low

$0.90

50-day MA

$1.11

200-day MA

$3.36

Analyst view

Analysts rate INVO Fertility, Inc. a hold (0 buy, 1 hold, 0 sell out of 1) with an average price target of $20.00.

Shareholding

Insiders

0.90%

Institutions

16.89%

Largest institutional holders

Fund	Stake
Mariner Wealth Advisors LLC	3.99%
Armistice Capital, LLC	2.87%
Geode Capital Management, LLC	0.67%
UBS Group AG	0.13%
Citigroup Inc	0.00%
SBI Securities Co Ltd	0.00%
Danske Bank A/S.	0.00%
ADAR1 Capital Management LLC	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for INVO Fertility, Inc. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.